http://rdf.ncbi.nlm.nih.gov/pubchem/patent/BR-102013019219-A2
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1d12bcc7ec09218e7d9b954222cfcbaa |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-09 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-02 |
| filingDate | 2013-07-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ad9479b85b3cf5f1e40bf53de30984d5 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_11028ab8175c7398303436db3325d34f |
| publicationDate | 2015-11-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | BR-102013019219-A2 |
| titleOfInvention | kit, its procurement process, and in vitro process for assessing cell viability and / or proliferation in relation to an active |
| abstract | kit, its procurement process, and in vitro process for assessing cell viability and / or proliferation in relation to an asset. The present invention provides products and processes useful as basic research tools for experimental cancer cell proliferation control tests and for testing active combinations and / or new pharmaceutical compositions for treating cancer. In a preferred embodiment, the products and processes of the invention are useful in detecting / quantifying chemoresistance and / or chemosensitivity in vitro, which contributes to better treatment selection for patients with various types of cancer. |
| priorityDate | 2013-07-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 20.